Academic and Research Skills
Basic Science
Clinical Research
Developmental Biology
General Pediatrics
Global Neonatal & Children's Health
Neonatology
Jon Watchko, MD
Professor Emeritus
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Cynthia Bearer, MD, PhD (she/her/hers)
Professor of Pediatrics
Pediatrics
CWRU
Cleveland Hts, Ohio, United States
David Stevenson, MD (he/him/his)
Harold K Faber Professor of Pediatrics
Stanford University School of Medicine
Stanford, California, United States
Session
Description: The annual symposium will explore the mechanisms underlying the development of hazardous hyperbilirubinemia and bilirubin neurotoxicity, highlighting their clinical implications. This year’s program features two leading experts in the field. Dr. Robert D. Christensen will review the laboratory tests used in the diagnosis of neonatal hemolysis and highlight the use of end-tidal carbon monoxide (CO), corrected for ambient CO (ETCOc), measurements as a diagnostic tool. Dr. Michael Kaplan will highlight the role glucose-6-phosphate dehydrogenase (G6PD) deficiency plays in hazardous hyperbilirubinemia risk and the varied temporal patterns of postnatal hyperbilirubinemia observed in this condition. A better understanding of neonatal hemolysis and hemolytic conditions that drive the development of hazardous hyperbilirubinemia will improve clinical practice and reduce the incidence of bilirubin neurotoxicity globally.
Speaker: Robert D. Christensen, MD (he/him/his) – University of Utah School of Medicine
Speaker: Michael Kaplan, MB ChB (he/him/his) – Hebrew University, Jerusalem, Israel